Syngen Biotech Co., Ltd. (8279)
TWSE
Closed
Nov 6, 2026
Day's Range
78.6052 wk Range
77.60Overview - 8279 - Syngen Biotech Co., Ltd.
Key Statistics
Valuation
Enterprise Value
2.10B
P/E (Trailing)
9.53
PEG Ratio
0.69
Price / Sales (TTM)
1.04
Price / Book
0.91
EV / EBITDA
5.72
Profitability
Gross Margin
31.46%
Profit Margin
11.00%
Operating Margin
14.17%
Return on Assets
5.30%
Return on Equity
9.84%
Ownership
Shares Outstanding
27.10M
Float
10.96M
Held by Insiders
63.54%
Held by Institutions
4.69%
Price stats
Beta
0.12
50-Day Avg
80.39
200-Day Avg
98.68
Dividends
Payout Ratio
60.10%
Frequency
Annual
Market Cap - 8279 - Syngen Biotech Co., Ltd.
Peers - 8279 - Syngen Biotech Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
Profile Summary - 8279 - Syngen Biotech Co., Ltd.
About
Syngen Biotech Co., Ltd. is a biotechnology company specializing in the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. Established in 1999 and headquartered in Tainan, Taiwan, the company focuses on advanced processes such as strain identification, microorganism fermentation, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
